Sb. Boppana et al., Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus, PEDIATRICS, 104(1), 1999, pp. 55-60
Objectives. To determine the frequency of symptomatic congenital cytomegalo
virus (CMV) infection in the offspring of women with a recurrent maternal C
MV infection and to characterize the demographic and newborn findings.
Methods. Study subjects consisted of infants with symptomatic congenital CM
V infection identified by a newborn virologic screening program at the Univ
ersity of Alabama Hospital between 1991 and 1997 and were enrolled in a lon
g-term follow-up study. Maternal infections were categorized by an analysis
of archival serum specimens collected before pregnancy and at the time of
delivery. Demographic data and clinical findings at birth were collected fr
om maternal and newborn hospital records and from parents at the time of in
itial evaluation.
Results. Of the 47 infants with symptomatic congenital CMV infection identi
fied during the study period, 8 were born to mothers with a confirmed nonpr
imary or recurrent CMV infection. The type of maternal infection could be a
scertained in only similar to 43% (20/47) of the children with symptomatic
congenital CMV infection born at the University of Alabama Hospital during
the study period. There were no significant differences in demographic char
acteristics of the recurrent infection group and the infants who were born
to mothers with either primary CMV infection during pregnancy or unclassifi
ed maternal infection. Similarly, the range of severity of clinical abnorma
lities during the newborn period did not differ in the two groups of childr
en. Furthermore, there were no significant differences in the incidence of
sequelae at long-term follow-up in the two groups of children.
Conclusions. Symptomatic congenital CMV infection can occur after a nonprim
ary or recurrent maternal infection. However, the exact incidence of sympto
matic congenital CMV infection among children born to women with preexistin
g immunity remains to be defined.